Skip to main content
. 2022 Apr 21;24(3):221–231. doi: 10.7461/jcen.2022.E2021.10.003

Table 2.

Predictors of favorable clinical outcome in univariate and multivariate logistic regression analyses

Univariate
Multivariate
OR (95% CI) p-value OR (95% CI) p-value
Age (<70 yr) 1.58 (1.02-2.07) 0.012* 1.39 (1.04-1.63) 0.022*
Gender (male) 1.19 (0.68-2.06) 0.536
Hypertension 0.77 (0.44-1.35) 0.363
Diabetic mellitus 0.92 (0.49-1.71) 0.802
Atrial fibrillation 1.11 (0.63-1.94) 0.715
Coronary artery disease 1.68 (0.70-2.22) 0.241
Prior stroke or TIA 0.54 (0.24-1.18) 0.224
Dyslipidemia 1.15 (0.68-1.96) 0.594
Body mass index ≥25 kg/m2 0.86 (0.48-1.53) 0.613
PLR (<145) 1.44 (1.04-2.20) 0.010* 1.29 (1.06-2.06) 0.016*
PNR (>41) 1.32 (1.08-1.88) 0.012* 1.22 (1.10-1.62) 0.022*
PWR (>25) 1.21 (1.06-1.92) 0.039* 1.14 (0.82-2.02) 0.075
hsCRP (<1 mg/L) 1.22 (1.04-1.64) 0.042* 1.18 (0.96-1.82) 0.068
Intravenous thrombolysis 0.74 (0.43-1.22) 0.261 1.64 (0.82-3.42) 0.202
ASPECTS (>8) 2.42 (1.44-5.08) 0.008* 2.24 (1.64-4.08) 0.012*
Initial NIHSS (<8) 3.76 (2.22-6.34) <0.001 3.64 (2.21-6.01) 0.002
Successful recanalization 2.42 (1.03-5.22) 0.027 2.27 (1.17-4.43) 0.036
First pass reperfusion 1.25 (0.54-1.72) 0.157 1.22 (0.68-1.66) 0.180
sICH 0.14 (0.03-0.54) 0.002 0.14 (0.04-0.52) 0.003
Hemorrhagic transformation 0.87 (0.68-1.74) 0.227
*

Statistically significant

OR, odds ratio; CI, confidence interval; TIA, transient ischemic attack; PLR, platelet-to-lymphocyte ratio; PNR, platelet-to-neutrophil ratio; PWR, platelet-to-white blood cell ratio; hsCRP, high-sensitivity C-reactive protein; ASPECTS, alberta stroke program early CT score; NIHSS, national institutes of health stroke scale; sICH, symptomatic intracerebral hemorrhage